Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women
To access this article, please choose from the options below
The THEBES Study Group participants are listed in the Appendix.
The THEBES study was supported by NV Organon (Oss, the Netherlands; protocol 32972). NV Organon funded the study, contributed to its design, oversaw quality control at the clinical centers including periodic site visits, and validated the data collected by the centers. The sponsor did not have access to the blinding code, and played no role in collecting or adjudicating disease outcomes. The first draft of the manuscript has been prepared by an independent medical writing group. D.F.A., S.H., A.F., J.C.G., J.R., and S.O.S. are consultants and have received lecture fees and grant support from Organon. J.F. has a contractual relationship with Organon for this study. W.d.H., V.S., and F.A.H. are employees of Organon.
PII: S0015-0282(07)00098-2
doi:10.1016/j.fertnstert.2006.12.052
© 2007 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

